-transparent.png){kind=logo}
The clinical reaction and the immunological response to influenza virus vaccine were studied in 43 B-cell chronic lymphocytic leukaemia patients. The Vaxigrip vaccine was administered containing the antigens A/Ghizhou/54/89, A/Singapore/6/86, and B/Yamagata/16/88. The side-effects observed were minimal and well tolerated. Antibody production with titres > 1:20 on day 15 was observed at least for one antigen in 35 patients (81%). In 23 of them (63%) this response was retained on days 30 and 60. Patients with IgG levels (< 700 mg/dl) responded less well as compared to those having normal IgG levels (> 700 mg/dl).
Related Publications
D A Gribabis, and
P Panayiotidis, and
V A Boussiotis, and
C Hannoun, and
G A Pangalis
January 1995,
Acta haematologica,
D A Gribabis, and
P Panayiotidis, and
V A Boussiotis, and
C Hannoun, and
G A Pangalis
September 2001,
European journal of internal medicine,
D A Gribabis, and
P Panayiotidis, and
V A Boussiotis, and
C Hannoun, and
G A Pangalis
January 1998,
Acta haematologica,
D A Gribabis, and
P Panayiotidis, and
V A Boussiotis, and
C Hannoun, and
G A Pangalis
September 1979,
Australian paediatric journal,
D A Gribabis, and
P Panayiotidis, and
V A Boussiotis, and
C Hannoun, and
G A Pangalis
August 1994,
British journal of haematology,
D A Gribabis, and
P Panayiotidis, and
V A Boussiotis, and
C Hannoun, and
G A Pangalis
April 2005,
British journal of cancer,
D A Gribabis, and
P Panayiotidis, and
V A Boussiotis, and
C Hannoun, and
G A Pangalis
November 1981,
British journal of haematology,
D A Gribabis, and
P Panayiotidis, and
V A Boussiotis, and
C Hannoun, and
G A Pangalis
February 1981,
Haematologica,
D A Gribabis, and
P Panayiotidis, and
V A Boussiotis, and
C Hannoun, and
G A Pangalis
June 2001,
Clinical and laboratory haematology,
D A Gribabis, and
P Panayiotidis, and
V A Boussiotis, and
C Hannoun, and
G A Pangalis
June 2004,
Leukemia & lymphoma,
